Comparison of the Efficacy of Different Exercise Modes on MCI Adults: A Network Meta-Analysis

Changjiang Qiu1,2, Jiaxin Han1,2, Yao Xie3

  • 1Hunan University of Chinese Medicine, Changsha, China.

Brain and Behavior
|August 22, 2025
PubMed
Abstract

Insights

Combination training is the most effective exercise for improving cognitive function in individuals with mild cognitive impairment (MCI). This approach significantly boosts scores on the MoCA and MMSE tests, potentially slowing disease progression.

Area of Science:

  • Neurology
  • Gerontology
  • Exercise Science

Background:

  • Mild cognitive impairment (MCI) represents a preclinical stage of Alzheimer's disease (AD).
  • MCI patients exhibit a significantly higher annual progression rate to dementia (10%-15%) compared to the general elderly population (1%-2%).

Purpose of the Study:

  • To evaluate the efficacy of different exercise modalities in improving cognitive function among adults with MCI.
  • To conduct a network meta-analysis (NMA) comparing various exercise interventions for MCI.

Main Methods:

  • A comprehensive literature search was performed across Embase, PubMed, Cochrane Library, and Web of Science for relevant randomized controlled trials (RCTs).
  • Data extraction and quality assessment were conducted independently by two reviewers.
  • Statistical analysis was performed using RevMan 5.4, Stata 15, and R 4.4.1.

Main Results:

  • The network meta-analysis included 35 studies involving 2717 participants.
  • Combination training (CT) demonstrated the greatest improvement in Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) scores for MCI patients.
  • Resistance training and sensorimotor training were identified as the next most effective interventions for enhancing MMSE and MoCA scores, respectively.

Conclusions:

  • Combination training is the optimal exercise intervention for enhancing MoCA and MMSE scores in MCI patients.
  • Exercise, particularly combination training, shows potential in mitigating the progression of MCI.
  • Further large-scale, double-blind clinical trials are warranted to validate these findings.